Wells Fargo’s Monogram Orthopaedics MGRM Stock Holding History

Wells Fargo’s Portfolio MGRM Stock Details MGRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,500	Closed	-$8.8K	–	7269
2025 Q3	$8.8K	Sell	1,500 -2,400	-62%	-$12.8K	﹤0.01%	5970
2025 Q2	$11.3K	Sell	3,900 -8,097	-67%	-$21.8K	﹤0.01%	5922
2025 Q1	$35.3K	Buy	11,997 +400	+3%	+$1.06K	﹤0.01%	5504
2024 Q4	$27.5K	Buy	11,597 +8,597	+287%	+$20.2K	﹤0.01%	5678
2024 Q3	$7.95K	Buy	3,000 +2,000	+200%	+$5.21K	﹤0.01%	5845
2024 Q2	$2.15K	Sell	1,000 -5,000	-83%	-$11K	﹤0.01%	6007
2024 Q1	$14.6K	Sell	6,000 -500	-8%	-$1.47K	﹤0.01%	5654
2023 Q4	$22.4K	Buy	6,500 +1,000	+18%	+$3.01K	﹤0.01%	5603
2023 Q3	$14.3K	Buy	5,500 +500	+10%	+$2.1K	﹤0.01%	5713
2023 Q2	$19.9K	Buy	+5,000	New	+$25.9K	﹤0.01%	5738

Wells Fargo's MGRM Position: Q4 2025 in Review

Wells Fargo sold out of Monogram Orthopaedics (MGRM) in Q4 2025, closing a stake of 1,500 shares — an estimated $8.8K sold.

Wells Fargo first reported a position in MGRM in Q2 2023 and held it in 10 quarters. The position peaked at $35.3K in Q1 2025. 0 funds tracked by Wall St. Rank hold MGRM as of Q4 2025.

Wells Fargo reported no remaining Monogram Orthopaedics position as of Q4 2025 after selling out during the quarter.
Wells Fargo sold 1,500 Monogram Orthopaedics shares in Q4 2025, an estimated $8.8K.
Wells Fargo first reported a position in Monogram Orthopaedics in Q2 2023 and held it in 10 quarters.
Wells Fargo's Monogram Orthopaedics position peaked at $35.3K in Q1 2025.
0 funds tracked by Wall St. Rank held Monogram Orthopaedics as of Q4 2025.

Based on Wells Fargo's 13F filing for Q4 2025, filed 13 Feb 2026.